JANUET 50/850 MG TABLETS

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Disponibbli minn:

MERCK SHARP & DOHME ISRAEL LTD

Kodiċi ATC:

A10BA02

Għamla farmaċewtika:

TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

MERCK SHARP & DOHME CORP., USA

Grupp terapewtiku:

METFORMIN

Indikazzjonijiet terapewtiċi:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Data ta 'l-awtorizzazzjoni:

2008-12-01